News Image

Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Provided By GlobeNewswire

Last update: Mar 25, 2025

Successfully Completed Private Placements with Aggregate Gross Proceeds of Approximately $125 Million to Support Advancement of Two Registrational Studies for TNX-103 in PH-HFpEF and Fund Operations through 2027

Read more at globenewswire.com

TENAX THERAPEUTICS INC

NASDAQ:TENX (10/22/2025, 8:04:53 PM)

7.4

+0.18 (+2.49%)



Find more stocks in the Stock Screener

Follow ChartMill for more